Nav: Home

New studies show no long term effects of antidepressant use during pregnancy

September 16, 2015

The use of antidepressants during pregnancy has no long term neurodevelopmental or behavioural effects on the child, however they may be associated with an increased risk of postpartum haemorrhage, suggests the findings from three studies published in BJOG: An International Journal of Obstetrics and Gynaecology (BJOG).

Depression and anxiety are the most common mental health problems during pregnancy, with around 12% of women in the UK experiencing depression at some point during pregnancy and the postnatal period. The use of antidepressants such as selective serotonin reuptake inhibitors (SSRIs) to treat depression during pregnancy has become increasingly common, however, it is unclear whether any increased risk to the fetus, and health problems for the woman or baby, can be attributed directly to these drugs or may be caused by other factors. The research published today examines the effects SSRI use on the health of both the mother and the long term development of the child.

A study from the Norwegian Institute of Public Health looked at the effects of prenatal exposure to SSRIs on motor skill development at 3 years old in 51,404 children from the Norwegian Mother and Child Cohort Study. In this cohort 159 mothers reported a prolonged use of SSRIs during pregnancy. Their children had a slight delay in the development of fine and gross motor skills compared to children unexposed during pregnancy. However, the authors of this paper acknowledge that the numbers are so small, no change in clinical practice is warranted.

Marte Handal, lead author of the study from the Norwegian Institute of Public Health said:

"Our results show that treatment with SSRIs during longer time periods in pregnancy was weakly associated with a delayed motor development at age three. However, only a very small number of children had a severe delay. Even though we did take into account maternal symptoms of depression we still did not have complete information on the severity of the maternal depression in the different groups. Effective treatment of depression during pregnancy is essential and these results should not discourage healthcare professionals from prescribing or continuing antidepressant treatment to those who need it."

In another study, an Australian team analysed data from 49,000 women registered on the Danish National Birth Cohort, to examine the impact of prenatal exposure to SSRIs on behavioural problems at aged 7. Results found that untreated prenatal depression (231 children) was associated with an increased risk of problem behaviour in the children, hyperactivity, inattention, and peer problems. This increased risk was not seen in the children (210 children) whose mothers took antidepressants, including SSRIs.

In a separate study, the same team examined the risk of postpartum haemorrhage (the loss of between 500 to 1,000ml of blood within the first 24 hours after giving birth) in mothers taking antidepressants in the final three months of their pregnancy, at the Women's and Children's Hospital in Adelaide, Australia. For women without psychiatric illness (28,000 women) or who were not taking antidepressants (1,292) the risk of postpartum haemorrhage was 11%. This increased to 16% for women taking antidepressants (558). Risk of severe postpartum haemorrhage and of postpartum anaemia were almost doubled by SSRI use.

Dr Luke Grzeskowiak, lead author of the studies from The University of Adelaide, Australia, said:

"It is reassuring to find that prenatal exposure to antidepressants did not affect a child's behaviour at age 7, however as with any medication, the benefits and risks but always be considered.

"Regarding our other study, overall the risks for postpartum haemorrhage are largely unknown. We found separate increases in risk with placenta praevia, prolonged labour, hypertension and assisted vaginal delivery, as well as the increased risk seen with antidepressant use. However we did not have data on known risks such as use of oxytocin during delivery, nor did we have any data on the severity of the underlying maternal psychiatric illness. Consequently, it is possible that the women who took antidepressants late in pregnancy were those with the most severe illness and it is this which is responsible for the increased risk of postpartum haemorrhage and not the antidepressant. Based on this study alone we do not recommend that women stop taking medication for depression during pregnancy, but are closely monitored in order to reduce the risk of any potential increased risk of bleeding as much as possible."

John Thorp, BJOG Deputy Editor-in-chief said:

"These studies add to a growing body of evidence about the safety of taking antidepressants during pregnancy. While there are some increased risks, the evidence so far seems to be that the risks of untreated depression outweigh the risks of taking them. But the more we understand the better prepared the medical profession will be to help women through their pregnancy and birth."

Royal College of Obstetricians and Gynaecologists response to BJOG studies on SSRI use in pregnancy Dr Patrick O'Brien, a maternal mental health expert and spokesperson for the Royal College of Obstetricians and Gynaecologists (RCOG), said:

"The decision whether or not to use SSRIs during pregnancy must be considered on an individual basis as untreated maternal depression can itself be harmful. Pregnant women and mothers can be reassured from these studies which suggest there are no clinically important long term neurodevelopmental or behavioural problems associated with taking SSRIs.

"While it is useful for women to be aware that SSRI use may increase the risk of postpartum haemorrhage, more research needs to be done to understand what is behind this increased risk. Women should not stop taking their medication without first discussing their options with their doctor and if necessary extra precautions can be taken to prevent postpartum haemorrhage at the time of birth."
-end-


Wiley

Related Depression Articles:

Tackling depression by changing the way you think
A thought is a thought. It does not reflect reality.
How depression can muddle thinking
Depression is associated with sadness, fatigue and a lack of motivation.
Neuroimaging categorizes 4 depression subtypes
Patients with depression can be categorized into four unique subtypes defined by distinct patterns of abnormal connectivity in the brain, according to new research from Weill Cornell Medicine.
Studies suggest inflammatory cytokines are associated with depression and psychosis, and that anti-cytokine treatment can reduce depression symptoms
Studies presented at this year's International Early Psychosis Association meeting in Milan, Italy, (Oct.
Is depression in parents, grandparents linked to grandchildren's depression?
Having both parents and grandparents with major depressive disorder was associated with higher risk of MDD for grandchildren, which could help identify those who may benefit from early intervention, according to a study published online by JAMA Psychiatry.
Postpartum depression least severe form of depression in mothers
Postpartum depression -- a household term since actress Brooke Shields went public in 2005 about her struggle with it -- is indeed serious.
Tropical Depression 1E dissipates
Tropical Depression 1E or TD1E didn't get far from the time it was born to the time it weakened to a remnant low pressure area along the southwestern coast of Mexico.
Diagnosing depression before it starts
MIT researchers have found that brain scans may identify children who are vulnerable to depression, before symptoms appear.
Men actually recommend getting help for depression
Participants in a national survey read a scenario describing someone who had depressed symptoms.
Depression too often reduced to a checklist of symptoms
How can you tell if someone is depressed? The Diagnostic and Statistical Manual of Mental Disorders (DSM) -- the 'bible' of psychiatry -- diagnoses depression when patients tick off a certain number of symptoms on the DSM checklist.

Related Depression Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Climate Crisis
There's no greater threat to humanity than climate change. What can we do to stop the worst consequences? This hour, TED speakers explore how we can save our planet and whether we can do it in time. Guests include climate activist Greta Thunberg, chemical engineer Jennifer Wilcox, research scientist Sean Davis, food innovator Bruce Friedrich, and psychologist Per Espen Stoknes.
Now Playing: Science for the People

#527 Honey I CRISPR'd the Kids
This week we're coming to you from Awesome Con in Washington, D.C. There, host Bethany Brookshire led a panel of three amazing guests to talk about the promise and perils of CRISPR, and what happens now that CRISPR babies have (maybe?) been born. Featuring science writer Tina Saey, molecular biologist Anne Simon, and bioethicist Alan Regenberg. A Nobel Prize winner argues banning CRISPR babies won’t work Geneticists push for a 5-year global ban on gene-edited babies A CRISPR spin-off causes unintended typos in DNA News of the first gene-edited babies ignited a firestorm The researcher who created CRISPR twins defends...